Lintex enterprise founded in 1991 takes its begging from scientific research and development of Saint-Petersburg State University of Technology and Design and is considered to be one of the first-rate domestic manufacturers of sterile sutures.

Lintex, LLC develops and produces up-to-date surgical sutures, surgical meshes, designed for hernioplasty, treatment of stress urinary incontinence (SUI) and pelvic organ prolapse (POP), wound closures, means for prevention and management of post-operative adhesions. 

All assortment items are registered and certified.

Goods quality assurance at all manufacturing stages is one of the main questions for the company performance.

Lintex, LLC has introduced and applies the Quality Management System according to ISO 9000:2000 (GOST R), EN ISO 9001:2000 and EN ISO 13485:2003 (SAS Swiss system) requirements in terms of development, production and sales of medical devices.

In full compliance with Directive 93/42/ЕЕС requirements Lintex, LLC products are approved to be secure medical devices and have CE marking.

Scientific and practical researches are considered to be Lintex, LLC innovative priority guidelines. 22 Lintex patented technologies are being widely applied in the company’s manufacturing process. Scientific studies are being actively developed together with other leading medical and clinical institutes.

Let us kindly invite you to collaborate with us!